Tag: clinical trials

Case Studies: Monitoring Plan & Risk Management Plan That Improved Approvals and Inspection Outcomes

November 20, 2025November 16, 2025 digi

Case Studies: Monitoring Plan & Risk Management Plan That Improved Approvals and Inspection Outcomes Case Studies: Monitoring Plan & Risk Management Plan That Improved Approvals and Inspection Outcomes Clinical trials are essential processes for validating the efficacy and safety of new medical interventions. Given the complexity and regulatory scrutiny involved in clinical trial systems, well-structured…

Monitoring Plan & Risk Management Plan

Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels

November 20, 2025 digi

Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels Case Studies: Protocol Redesigns That Dramatically Cut Deviation Levels Introduction to Protocol Deviations in Clinical Trials In the realm of clinical research, protocol deviations are among the critical factors that can impact the integrity and reliability of clinical trial data. A protocol deviation occurs when there…

Protocol Feasibility Lessons Learned

Cross-Functional Feasibility Reviews Focused on Deviation Prevention

November 20, 2025November 16, 2025 digi

Cross-Functional Feasibility Reviews Focused on Deviation Prevention Cross-Functional Feasibility Reviews Focused on Deviation Prevention Introduction to Feasibility Reviews in Pharma Clinical Trials Feasibility reviews are essential components of the clinical trial planning process, especially within the pharmaceutical industry. These reviews gather insights from multiple departments—clinical operations, regulatory affairs, and medical affairs—to assess the practical aspects…

Protocol Feasibility Lessons Learned

Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators

November 20, 2025November 16, 2025 digi

Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Clinical trials represent a critical pathway for the development of innovative therapies. However, with the rigorous regulatory frameworks established by organizations such as the FDA, EMA, and MHRA, it is essential for clinical…

Journal Policies & Preprints

KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios

November 20, 2025November 16, 2025 digi

KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios In the ever-evolving landscape of clinical research, the need for transparency and compliance has never been more crucial. With the increasing complexity of clinical research trials and the imperative nature of…

Journal Policies & Preprints

Metrics and KPIs to Monitor the Quality and Timeliness of Monitoring Plan & Risk Management Plan

November 20, 2025November 16, 2025 digi

Metrics and KPIs to Monitor the Quality and Timeliness of Monitoring Plan & Risk Management Plan Metrics and KPIs to Monitor the Quality and Timeliness of Monitoring Plan & Risk Management Plan In the complex realm of clinical trials, the necessity for robust monitoring plans and effective risk management frameworks cannot be overstated. Both the…

Monitoring Plan & Risk Management Plan

Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates

November 20, 2025November 16, 2025 digi

Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates Feasibility Lessons From DCT and Hybrid Trials With High Deviation Rates In the realm of pharmaceutical clinical trials, hybrid and decentralized clinical trials (DCTs) are transforming the way studies are conducted. However, high deviation rates can introduce significant challenges. This article presents a comprehensive,…

Protocol Feasibility Lessons Learned

Translating Deviation Root Causes Into Protocol Amendments and New SOPs

November 20, 2025 digi

Translating Deviation Root Causes Into Protocol Amendments and New SOPs Translating Deviation Root Causes Into Protocol Amendments and New SOPs The landscape of clinical trial management is an intricate realm, particularly for those involved in protocol deviations and non-compliance. With the ever-evolving regulatory frameworks existing in the US, EU, and UK, it is imperative that…

Protocol Feasibility Lessons Learned

Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials

November 20, 2025November 16, 2025 digi

Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials In the rapidly evolving landscape of clinical research, transparency and timely dissemination of findings have become paramount. This step-by-step tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Journal Policies & Preprints

Digital Tools and Automation to Streamline Journal Policies & Preprints

November 20, 2025November 16, 2025 digi

Digital Tools and Automation to Streamline Journal Policies & Preprints In today’s clinical research landscape, transparency and efficient communication of study results have become paramount. The integration of digital tools and automation in managing journal policies and preprints can significantly enhance compliance and accessibility of findings. This article outlines a comprehensive step-by-step guide on how…

Journal Policies & Preprints